Information Journal Paper
APA:
Copy. (2017). Safety and tolerability of empagliflozin in patients with type 2 diabetes: pooled analysis of phase I-III clinical trials. ADVANCES IN THERAPY, 34(7), 1707-1726. SID. https://sid.ir/paper/723296/en
Vancouver:
Copy. Safety and tolerability of empagliflozin in patients with type 2 diabetes: pooled analysis of phase I-III clinical trials. ADVANCES IN THERAPY[Internet]. 2017;34(7):1707-1726. Available from: https://sid.ir/paper/723296/en
IEEE:
Copy, “Safety and tolerability of empagliflozin in patients with type 2 diabetes: pooled analysis of phase I-III clinical trials,” ADVANCES IN THERAPY, vol. 34, no. 7, pp. 1707–1726, 2017, [Online]. Available: https://sid.ir/paper/723296/en